What public companies just told the SEC about AI, read straight from the filings. Every quote links the original document.
CoreWeave Claims First NVIDIA Vera Rubin NVL72 Validation
A convertible note investor presentation filed as an 8-K by CoreWeave (CRWV) on September 17 leads with five milestone claims. The first: being "the first AI cloud provider to bring up and validate NVIDIA's Vera Rubin NVL72." That is a hardware claim tied to NVIDIA's latest GPU system, filed before debt investors rather than announced in a press release. On the same slide, CoreWeave listed a separate milestone:
Launched unified agentic AI capabilities, including Sandboxes and ARIA to fuel the AI loop
The context is a fundraising document, so the claims serve a commercial purpose. But the Vera Rubin specificity and the agentic AI launch described in formal securities materials are worth noting alongside the record MLPerf benchmarks CoreWeave also cited in the same filing.
AI Inventorship Risk Appears in Two Separate S-1 Amendments
Two unrelated companies filing S-1 amendments on September 18 included nearly identical new risk factors about AI-assisted patents. Spectral Capital (FCCN) put it plainly:
Our use of artificial intelligence tools in our research, development, and innovation processes could give rise to inventorship challenges that affect the validity or enforceability of our patent applications.
Spectral uses AI in its own R&D processes, so the risk is grounded in actual practice. Retension Pharmaceuticals raised the same category from the opposite direction: third parties could challenge future patents "as invalid for lack of a human inventor" given evolving law around AI-assisted inventions. Two companies in different sectors, technology and pharmaceuticals, disclosing this in the same three-day window suggests the language is becoming a standard risk factor rather than a company-specific disclosure.
Axe Compute Sells Cancer Diagnostics Unit to Focus on GPU Cloud
Axe Compute (AGPU) announced in a September 15 8-K that it sold Helomics Corporation, its wholly-owned cancer diagnostics AI laboratory, to DataMEDS AI in an all-stock transaction. Axe Compute receives common shares and share equivalents in DataMEDS in return. The filing describes Axe Compute as "a neocloud AI infrastructure platform" and frames Helomics as legacy, signaling that the company sees its future in GPU-as-a-Service. The acquirer, DataMEDS, is described as "a Health IT company vertically integrating health data acquisition and transfer," so the diagnostics technology moves to a buyer for whom it is central rather than peripheral.
Eightco Discloses $90 Million in OpenAI Special Purpose Vehicles
Eightco Holdings (ORBS) filed an 8-K on September 17 describing its treasury as exposure to three stated mega-trends: artificial intelligence, digital identity, and the creator economy. The AI position is the largest piece:
Eightco has invested approximately $90 million in special purpose vehicles with exposure to equity interests in the parent comp…
That $90 million represents 24% of ORBS treasury holdings by the company's own accounting, with Worldcoin at 29% and Beast Industries at 5%. Eightco is a publicly traded vehicle built explicitly to hold private-market exposure to these assets. Board member Tom Lee stated in the same filing that the industry sees "few trade-offs with growth" in the near term, framing the position as opportunistic.
Agentic AI Enters a 10-K, an S-4, and a Fund Prospectus in Three Days
Nutanix (NTNX) filed its 10-K on September 18 and listed "agentic AI" alongside generative AI as a named category of opportunity and risk in its forward-looking statements, placing the term in an annual report rather than a marketing document. On the same day, Themes ETF Trust filed a 485APOS prospectus amendment describing its underlying holding SymphonyAI as a company whose products "use predictive, generative and agentic AI to support operational workflows and business decision-making." Themes ETF Trust is flagged as a first-time EDGAR filer for the phrase. Genpact (G) also used "agentic AI" in an S-4 merger registration this week, listing it as a specific technology risk. Three different filing types carrying the same term across three days is a reasonable marker of the vocabulary settling into standard regulatory language.